tiprankstipranks
Trending News
More News >
Earth Science Tech Inc (ETST)
OTHER OTC:ETST
US Market
Advertisement

Earth Science Tech (ETST) AI Stock Analysis

Compare
45 Followers

Top Page

ETST

Earth Science Tech

(OTC:ETST)

Select Model
Select Model
Select Model
Neutral 62 (OpenAI - 4o)
Rating:62Neutral
Price Target:
$0.16
▲(2.50% Upside)
Earth Science Tech's overall stock score reflects its strong financial recovery and growth, particularly in revenue and cash flow. The technical indicators suggest neutral to slightly overbought conditions, while the valuation is reasonable. The recent corporate event highlights successful business strategies, contributing positively to the score.
Positive Factors
Revenue Growth
Strong revenue growth indicates successful market penetration and product acceptance, enhancing long-term business sustainability.
Cash Flow Strength
Improved cash flow supports operational flexibility and investment capacity, crucial for sustaining growth and innovation.
Equity Position
A stronger equity position enhances financial stability and reduces risk, supporting long-term strategic initiatives.
Negative Factors
High Leverage
High leverage can limit financial flexibility and increase vulnerability to economic downturns, impacting long-term resilience.
Volatile Profit Margins
Volatile profit margins can affect predictability of earnings, complicating long-term financial planning and investment.
Past Financial Instability
Historical financial instability may indicate underlying issues that could resurface, posing risks to future performance.

Earth Science Tech (ETST) vs. SPDR S&P 500 ETF (SPY)

Earth Science Tech Business Overview & Revenue Model

Company DescriptionEarth Science Tech, Inc., a biotechnology company, focuses on delivering nutraceuticals, bioceuticals, and dietary supplements in the areas of health, wellness, nutrition, supplement, cosmetic, and alternative medicine worldwide. The company focuses on delivering nutritional and dietary supplements for the treatment of chronic pain, joint pain, inflammation, seizures, high blood pressure, memory loss, depression, weight management, nausea, aging, and overall wellness. Its products include hemp oils, vitamins, minerals, herbs, botanicals, personal care products, homeopathies, functional foods, and other products. The company markets its products in a range of formulations and delivery forms, including capsules, tablets, soft gels, chewables, liquids, creams, sprays, powders, and whole herbs through its retail store, clinics, pharmacies, as well as through online. It also provides medical equipment and devices. The company was formerly known as Ultimate Novelty Sports, Inc. and changed its name to Earth Science Tech, Inc. in March 2014. The company was incorporated in 2010 and is headquartered in Doral, Florida.
How the Company Makes MoneyETST generates revenue primarily through the sale of its health and wellness products, which include CBD-infused supplements and topical solutions. The company has established key revenue streams by targeting both direct-to-consumer sales through its online platform and wholesale distribution to retailers and health practitioners. Additionally, ETST has engaged in strategic partnerships and collaborations with other companies in the biotech and cannabis sectors, enhancing its product offerings and market reach. The company's ability to innovate and adapt to consumer trends in the wellness industry, along with its commitment to high-quality standards, plays a significant role in its financial performance.

Earth Science Tech Financial Statement Overview

Summary
Earth Science Tech has demonstrated substantial financial recovery and growth, particularly in revenue and cash flow metrics. While past financial instability and high leverage are concerns, recent improvements in profitability and equity position indicate a more stable future outlook.
Income Statement
60
Neutral
Earth Science Tech has shown impressive revenue growth, with a significant increase from $140,902 in 2021 to $33,117,624 in 2025. The gross profit margin has also improved, indicating better cost management. However, the net profit margin has been volatile due to fluctuating net income, impacting overall profitability stability.
Balance Sheet
55
Neutral
The company's debt-to-equity ratio has improved with a positive equity position as of 2025, contrasting with negative equity in earlier years. However, the relatively high total debt and liabilities still pose a financial stability risk. The return on equity has been erratic due to previous negative equity.
Cash Flow
65
Positive
Earth Science Tech's cash flow situation is strengthening, with significant growth in operating cash flow and positive free cash flow in recent years. The free cash flow to net income ratio suggests efficient cash generation from profits. However, earlier periods showed negative cash flows, indicating past challenges.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue33.84M33.12M11.95M48.54K14.12K140.90K
Gross Profit24.44M24.30M7.83M22.06K-8.52K39.93K
EBITDA3.38M3.54M1.04M-300.48K-224.28K-4.30M
Net Income2.79M3.25M812.14K144.58K6.66M-4.47M
Balance Sheet
Total Assets8.67M7.07M3.88M2.69M76.94K64.56K
Cash, Cash Equivalents and Short-Term Investments1.24M2.12M697.72K35.76K26.94K16.16K
Total Debt23.88K401.24K246.59K974.11K682.45K650.44K
Total Liabilities3.59M3.22M1.63M1.61M1.88M5.09M
Stockholders Equity5.08M3.85M2.25M1.08M-1.81M-5.03M
Cash Flow
Free Cash Flow2.80M3.62M1.18M-1.01M-166.39K-196.69K
Operating Cash Flow3.68M4.37M1.21M-1.01M-168.11K-196.69K
Investing Cash Flow-2.71M-1.88M-26.52K0.001.71K0.00
Financing Cash Flow-1.26M-1.72M-517.88K1.02M173.18K182.12K

Earth Science Tech Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.16
Price Trends
50DMA
0.16
Negative
100DMA
0.18
Negative
200DMA
0.16
Negative
Market Momentum
MACD
<0.01
Negative
RSI
50.58
Neutral
STOCH
93.83
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For ETST, the sentiment is Negative. The current price of 0.16 is above the 20-day moving average (MA) of 0.15, below the 50-day MA of 0.16, and below the 200-day MA of 0.16, indicating a neutral trend. The MACD of <0.01 indicates Negative momentum. The RSI at 50.58 is Neutral, neither overbought nor oversold. The STOCH value of 93.83 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for ETST.

Earth Science Tech Risk Analysis

Earth Science Tech disclosed 38 risk factors in its most recent earnings report. Earth Science Tech reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Earth Science Tech Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
62
Neutral
$45.32M16.3271.39%25.83%25.00%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
51
Neutral
$39.79M-12.47-13.08%12.21%69.91%
47
Neutral
$36.84M-16.67%-23.60%-179.33%
46
Neutral
$26.45M-1.11-53.29%-65.77%38.61%
41
Neutral
$59.66M-3.21-86.48%-90.04%44.40%
39
Underperform
$16.12M-0.65-63.82%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
ETST
Earth Science Tech
0.16
0.03
23.08%
TLPH
Talphera
1.23
0.48
64.00%
RMTI
Rockwell Med
0.99
-1.15
-53.74%
SCYX
SCYNEXIS
0.66
-0.57
-46.34%
CPIX
Cumberland Pharmaceuticals
2.39
1.15
92.74%
COSM
Cosmos Holdings
0.46
-0.29
-38.67%

Earth Science Tech Corporate Events

Business Operations and StrategyFinancial Disclosures
Earth Science Tech Reports Strong Q2 Financial Growth
Positive
Nov 12, 2025

On November 12, 2025, Earth Science Tech, Inc. announced its financial results for the second fiscal quarter ending September 30, 2025, showcasing significant growth. The company reported a 71.64% year-over-year increase in total assets, reaching $8.66 million, and an 18.48% rise in quarterly net profit to $0.94 million. These results reflect the company’s successful strategy in scaling its businesses and enhancing shareholder value through asset growth and share count reduction.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Dec 07, 2025